Isocitrate dehydrogenase (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Isocitrate dehydrogenase" in English language version.

refsWebsite

Global rank English rank

36nih.gov

4^th place

24doi.org

2^nd place

6semanticscholar.org

11^th place

8^th place

4harvard.edu

18^th place

17^th place

2rcsb.org

8,838^th place

8,783^rd place

1archive.org

6^th place

1uzh.ch

3,633^rd place

3,091^st place

archive.org

Cox M, Nelson DR, Lehninger AL (2005). Lehninger Principles of Biochemistry. San Francisco: W.H. Freeman. pp. 609–611. ISBN 0-7167-4339-6.

doi.org

PDB: 1CW7; Cherbavaz DB, Lee ME, Stroud RM, Koshland DE (January 2000). "Active site water molecules revealed in the 2.1 A resolution structure of a site-directed mutant of isocitrate dehydrogenase". Journal of Molecular Biology. 295 (3): 377–385. doi:10.1006/jmbi.1999.3195. PMID 10623532.
Corpas FJ, Barroso JB, Sandalio LM, Palma JM, Lupiáñez JA (November 1999). "Peroxisomal NADP-Dependent Isocitrate Dehydrogenase. Characterization and Activity Regulation during Natural Senescence". Plant Physiology. 121 (3): 921–928. doi:10.1104/pp.121.3.921. PMC 59455. PMID 10557241.
PDB: 1LWD; Ceccarelli C, Grodsky NB, Ariyaratne N, Colman RF, Bahnson BJ (November 2002). "Crystal structure of porcine mitochondrial NADP+-dependent isocitrate dehydrogenase complexed with Mn2+ and isocitrate. Insights into the enzyme mechanism". The Journal of Biological Chemistry. 277 (45): 43454–43462. doi:10.1074/jbc.M207306200. PMID 12207025.
Chen R, Yang H (November 2000). "A highly specific monomeric isocitrate dehydrogenase from Corynebacterium glutamicum". Archives of Biochemistry and Biophysics. 383 (2): 238–245. doi:10.1006/abbi.2000.2082. PMID 11185559.
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. (August 2021). "The 2021 WHO Classification of Tumors of the Central Nervous System: a summary". Neuro-Oncology. 23 (8): 1231–1251. doi:10.1093/neuonc/noab106. PMC 8328013. PMID 34185076.
Quartararo CE, Hazra S, Hadi T, Blanchard JS (March 2013). "Structural, kinetic and chemical mechanism of isocitrate dehydrogenase-1 from Mycobacterium tuberculosis". Biochemistry. 52 (10): 1765–1775. doi:10.1021/bi400037w. PMC 3706558. PMID 23409873.
Maeting I, Schmidt G, Sahm H, Stahmann KP (2000). "Role of a peroxisomal NADP-specific isocitrate dehydrogenase in the metabolism of the riboflavin overproducer Ashbya gossypii". Journal of Molecular Catalysis B: Enzymatic. 10 (1–3): 335–343. doi:10.1016/S1381-1177(00)00135-1.
Brewer KI, Greenlee EB, Higgs G, Yu D, Mirihana Arachchilage G, Chen X, et al. (December 2021). "Comprehensive discovery of novel structured noncoding RNAs in 26 bacterial genomes". RNA Biology. 18 (12): 2417–2432. doi:10.1080/15476286.2021.1917891. PMC 8632094. PMID 33970790. S2CID 234361097.
Yasutake Y, Watanabe S, Yao M, Takada Y, Fukunaga N, Tanaka I (September 2003). "Crystal structure of the monomeric isocitrate dehydrogenase in the presence of NADP+: insight into the cofactor recognition, catalysis, and evolution". The Journal of Biological Chemistry. 278 (38): 36897–36904. doi:10.1074/jbc.M304091200. PMID 12855708.
Aoshima M, Igarashi Y (March 2008). "Nondecarboxylating and decarboxylating isocitrate dehydrogenases: oxalosuccinate reductase as an ancestral form of isocitrate dehydrogenase". Journal of Bacteriology. 190 (6): 2050–2055. doi:10.1128/JB.01799-07. PMC 2258884. PMID 18203822.
Fedøy AE, Yang N, Martinez A, Leiros HK, Steen IH (September 2007). "Structural and functional properties of isocitrate dehydrogenase from the psychrophilic bacterium Desulfotalea psychrophila reveal a cold-active enzyme with an unusual high thermal stability". Journal of Molecular Biology. 372 (1): 130–149. doi:10.1016/j.jmb.2007.06.040. PMID 17632124.
Capper D, Zentgraf H, Balss J, Hartmann C, von Deimling A (November 2009). "Monoclonal antibody specific for IDH1 R132H mutation". Acta Neuropathologica. 118 (5): 599–601. doi:10.1007/s00401-009-0595-z. PMID 19798509. S2CID 36093146.
Zarei M, Hue JJ, Hajihassani O, Graor HJ, Katayama ES, Loftus AW, et al. (February 2022). "Clinical development of IDH1 inhibitors for cancer therapy". Cancer Treatment Reviews. 103: 102334. doi:10.1016/j.ctrv.2021.102334. PMID 34974243. S2CID 245547597.
Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, et al. (December 2010). "Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas" (PDF). Acta Neuropathologica. 120 (6): 707–718. doi:10.1007/s00401-010-0781-z. PMID 21088844. S2CID 7323032.
Molenaar RJ, Verbaan D, Lamba S, Zanon C, Jeuken JW, Boots-Sprenger SH, et al. (September 2014). "The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone". Neuro-Oncology. 16 (9): 1263–1273. doi:10.1093/neuonc/nou005. PMC 4136888. PMID 24510240.
Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, et al. (March 2010). "The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate". Cancer Cell. 17 (3): 225–234. doi:10.1016/j.ccr.2010.01.020. PMC 2849316. PMID 20171147.
Wang Y, Xiao M, Chen X, Chen L, Xu Y, Lv L, et al. (February 2015). "WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation". Molecular Cell. 57 (4): 662–673. doi:10.1016/j.molcel.2014.12.023. PMC 4336627. PMID 25601757.
Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, et al. (June 2010). "Cancer-associated IDH1 mutations produce 2-hydroxyglutarate". Nature. 465 (7300): 966. Bibcode:2010Natur.465..966D. doi:10.1038/nature09132. PMC 3766976. PMID 20559394.
Chowdhury R, Yeoh KK, Tian YM, Hillringhaus L, Bagg EA, Rose NR, et al. (May 2011). "The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases". EMBO Reports. 12 (5): 463–469. doi:10.1038/embor.2011.43. PMC 3090014. PMID 21460794.
Molenaar RJ, Radivoyevitch T, Maciejewski JP, van Noorden CJ, Bleeker FE (December 2014). "The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1846 (2): 326–341. doi:10.1016/j.bbcan.2014.05.004. PMID 24880135.
Amary MF, Damato S, Halai D, Eskandarpour M, Berisha F, Bonar F, et al. (November 2011). "Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2". Nature Genetics. 43 (12): 1262–1265. doi:10.1038/ng.994. PMID 22057236. S2CID 5592593.
Tarhonskaya H, Rydzik AM, Leung IK, Loik ND, Chan MC, Kawamura A, et al. (March 2014). "Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases". Nature Communications. 5: 3423. Bibcode:2014NatCo...5.3423T. doi:10.1038/ncomms4423. PMC 3959194. PMID 24594748.
Koivunen P, Lee S, Duncan CG, Lopez G, Lu G, Ramkissoon S, et al. (February 2012). "Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation". Nature. 483 (7390): 484–488. Bibcode:2012Natur.483..484K. doi:10.1038/nature10898. PMC 3656605. PMID 22343896.
Notarangelo G, Spinelli JB, Perez EM, Baker GJ, Kurmi K, Elia I, et al. (September 2022). "Oncometabolite d-2HG alters T cell metabolism to impair CD8⁺ T cell function". Science. 377 (6614): 1519–1529. Bibcode:2022Sci...377.1519N. doi:10.1126/science.abj5104. PMC 9629749. PMID 36173860. S2CID 252623286.

harvard.edu

ui.adsabs.harvard.edu

Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, et al. (June 2010). "Cancer-associated IDH1 mutations produce 2-hydroxyglutarate". Nature. 465 (7300): 966. Bibcode:2010Natur.465..966D. doi:10.1038/nature09132. PMC 3766976. PMID 20559394.
Tarhonskaya H, Rydzik AM, Leung IK, Loik ND, Chan MC, Kawamura A, et al. (March 2014). "Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases". Nature Communications. 5: 3423. Bibcode:2014NatCo...5.3423T. doi:10.1038/ncomms4423. PMC 3959194. PMID 24594748.
Koivunen P, Lee S, Duncan CG, Lopez G, Lu G, Ramkissoon S, et al. (February 2012). "Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation". Nature. 483 (7390): 484–488. Bibcode:2012Natur.483..484K. doi:10.1038/nature10898. PMC 3656605. PMID 22343896.
Notarangelo G, Spinelli JB, Perez EM, Baker GJ, Kurmi K, Elia I, et al. (September 2022). "Oncometabolite d-2HG alters T cell metabolism to impair CD8⁺ T cell function". Science. 377 (6614): 1519–1529. Bibcode:2022Sci...377.1519N. doi:10.1126/science.abj5104. PMC 9629749. PMID 36173860. S2CID 252623286.

nih.gov

pubmed.ncbi.nlm.nih.gov

PDB: 1CW7; Cherbavaz DB, Lee ME, Stroud RM, Koshland DE (January 2000). "Active site water molecules revealed in the 2.1 A resolution structure of a site-directed mutant of isocitrate dehydrogenase". Journal of Molecular Biology. 295 (3): 377–385. doi:10.1006/jmbi.1999.3195. PMID 10623532.
Corpas FJ, Barroso JB, Sandalio LM, Palma JM, Lupiáñez JA (November 1999). "Peroxisomal NADP-Dependent Isocitrate Dehydrogenase. Characterization and Activity Regulation during Natural Senescence". Plant Physiology. 121 (3): 921–928. doi:10.1104/pp.121.3.921. PMC 59455. PMID 10557241.
PDB: 1LWD; Ceccarelli C, Grodsky NB, Ariyaratne N, Colman RF, Bahnson BJ (November 2002). "Crystal structure of porcine mitochondrial NADP+-dependent isocitrate dehydrogenase complexed with Mn2+ and isocitrate. Insights into the enzyme mechanism". The Journal of Biological Chemistry. 277 (45): 43454–43462. doi:10.1074/jbc.M207306200. PMID 12207025.
Chen R, Yang H (November 2000). "A highly specific monomeric isocitrate dehydrogenase from Corynebacterium glutamicum". Archives of Biochemistry and Biophysics. 383 (2): 238–245. doi:10.1006/abbi.2000.2082. PMID 11185559.
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. (August 2021). "The 2021 WHO Classification of Tumors of the Central Nervous System: a summary". Neuro-Oncology. 23 (8): 1231–1251. doi:10.1093/neuonc/noab106. PMC 8328013. PMID 34185076.
Quartararo CE, Hazra S, Hadi T, Blanchard JS (March 2013). "Structural, kinetic and chemical mechanism of isocitrate dehydrogenase-1 from Mycobacterium tuberculosis". Biochemistry. 52 (10): 1765–1775. doi:10.1021/bi400037w. PMC 3706558. PMID 23409873.
Brewer KI, Greenlee EB, Higgs G, Yu D, Mirihana Arachchilage G, Chen X, et al. (December 2021). "Comprehensive discovery of novel structured noncoding RNAs in 26 bacterial genomes". RNA Biology. 18 (12): 2417–2432. doi:10.1080/15476286.2021.1917891. PMC 8632094. PMID 33970790. S2CID 234361097.
Yasutake Y, Watanabe S, Yao M, Takada Y, Fukunaga N, Tanaka I (September 2003). "Crystal structure of the monomeric isocitrate dehydrogenase in the presence of NADP+: insight into the cofactor recognition, catalysis, and evolution". The Journal of Biological Chemistry. 278 (38): 36897–36904. doi:10.1074/jbc.M304091200. PMID 12855708.
Aoshima M, Igarashi Y (March 2008). "Nondecarboxylating and decarboxylating isocitrate dehydrogenases: oxalosuccinate reductase as an ancestral form of isocitrate dehydrogenase". Journal of Bacteriology. 190 (6): 2050–2055. doi:10.1128/JB.01799-07. PMC 2258884. PMID 18203822.
Fedøy AE, Yang N, Martinez A, Leiros HK, Steen IH (September 2007). "Structural and functional properties of isocitrate dehydrogenase from the psychrophilic bacterium Desulfotalea psychrophila reveal a cold-active enzyme with an unusual high thermal stability". Journal of Molecular Biology. 372 (1): 130–149. doi:10.1016/j.jmb.2007.06.040. PMID 17632124.
Capper D, Zentgraf H, Balss J, Hartmann C, von Deimling A (November 2009). "Monoclonal antibody specific for IDH1 R132H mutation". Acta Neuropathologica. 118 (5): 599–601. doi:10.1007/s00401-009-0595-z. PMID 19798509. S2CID 36093146.
Zarei M, Hue JJ, Hajihassani O, Graor HJ, Katayama ES, Loftus AW, et al. (February 2022). "Clinical development of IDH1 inhibitors for cancer therapy". Cancer Treatment Reviews. 103: 102334. doi:10.1016/j.ctrv.2021.102334. PMID 34974243. S2CID 245547597.
Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, et al. (December 2010). "Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas" (PDF). Acta Neuropathologica. 120 (6): 707–718. doi:10.1007/s00401-010-0781-z. PMID 21088844. S2CID 7323032.
Molenaar RJ, Verbaan D, Lamba S, Zanon C, Jeuken JW, Boots-Sprenger SH, et al. (September 2014). "The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone". Neuro-Oncology. 16 (9): 1263–1273. doi:10.1093/neuonc/nou005. PMC 4136888. PMID 24510240.
Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, et al. (March 2010). "The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate". Cancer Cell. 17 (3): 225–234. doi:10.1016/j.ccr.2010.01.020. PMC 2849316. PMID 20171147.
Wang Y, Xiao M, Chen X, Chen L, Xu Y, Lv L, et al. (February 2015). "WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation". Molecular Cell. 57 (4): 662–673. doi:10.1016/j.molcel.2014.12.023. PMC 4336627. PMID 25601757.
Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, et al. (June 2010). "Cancer-associated IDH1 mutations produce 2-hydroxyglutarate". Nature. 465 (7300): 966. Bibcode:2010Natur.465..966D. doi:10.1038/nature09132. PMC 3766976. PMID 20559394.
Chowdhury R, Yeoh KK, Tian YM, Hillringhaus L, Bagg EA, Rose NR, et al. (May 2011). "The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases". EMBO Reports. 12 (5): 463–469. doi:10.1038/embor.2011.43. PMC 3090014. PMID 21460794.
Molenaar RJ, Radivoyevitch T, Maciejewski JP, van Noorden CJ, Bleeker FE (December 2014). "The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1846 (2): 326–341. doi:10.1016/j.bbcan.2014.05.004. PMID 24880135.
Amary MF, Damato S, Halai D, Eskandarpour M, Berisha F, Bonar F, et al. (November 2011). "Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2". Nature Genetics. 43 (12): 1262–1265. doi:10.1038/ng.994. PMID 22057236. S2CID 5592593.
Tarhonskaya H, Rydzik AM, Leung IK, Loik ND, Chan MC, Kawamura A, et al. (March 2014). "Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases". Nature Communications. 5: 3423. Bibcode:2014NatCo...5.3423T. doi:10.1038/ncomms4423. PMC 3959194. PMID 24594748.
Koivunen P, Lee S, Duncan CG, Lopez G, Lu G, Ramkissoon S, et al. (February 2012). "Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation". Nature. 483 (7390): 484–488. Bibcode:2012Natur.483..484K. doi:10.1038/nature10898. PMC 3656605. PMID 22343896.
Notarangelo G, Spinelli JB, Perez EM, Baker GJ, Kurmi K, Elia I, et al. (September 2022). "Oncometabolite d-2HG alters T cell metabolism to impair CD8⁺ T cell function". Science. 377 (6614): 1519–1529. Bibcode:2022Sci...377.1519N. doi:10.1126/science.abj5104. PMC 9629749. PMID 36173860. S2CID 252623286.

ncbi.nlm.nih.gov

Corpas FJ, Barroso JB, Sandalio LM, Palma JM, Lupiáñez JA (November 1999). "Peroxisomal NADP-Dependent Isocitrate Dehydrogenase. Characterization and Activity Regulation during Natural Senescence". Plant Physiology. 121 (3): 921–928. doi:10.1104/pp.121.3.921. PMC 59455. PMID 10557241.
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. (August 2021). "The 2021 WHO Classification of Tumors of the Central Nervous System: a summary". Neuro-Oncology. 23 (8): 1231–1251. doi:10.1093/neuonc/noab106. PMC 8328013. PMID 34185076.
Quartararo CE, Hazra S, Hadi T, Blanchard JS (March 2013). "Structural, kinetic and chemical mechanism of isocitrate dehydrogenase-1 from Mycobacterium tuberculosis". Biochemistry. 52 (10): 1765–1775. doi:10.1021/bi400037w. PMC 3706558. PMID 23409873.
Brewer KI, Greenlee EB, Higgs G, Yu D, Mirihana Arachchilage G, Chen X, et al. (December 2021). "Comprehensive discovery of novel structured noncoding RNAs in 26 bacterial genomes". RNA Biology. 18 (12): 2417–2432. doi:10.1080/15476286.2021.1917891. PMC 8632094. PMID 33970790. S2CID 234361097.
Aoshima M, Igarashi Y (March 2008). "Nondecarboxylating and decarboxylating isocitrate dehydrogenases: oxalosuccinate reductase as an ancestral form of isocitrate dehydrogenase". Journal of Bacteriology. 190 (6): 2050–2055. doi:10.1128/JB.01799-07. PMC 2258884. PMID 18203822.
Molenaar RJ, Verbaan D, Lamba S, Zanon C, Jeuken JW, Boots-Sprenger SH, et al. (September 2014). "The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone". Neuro-Oncology. 16 (9): 1263–1273. doi:10.1093/neuonc/nou005. PMC 4136888. PMID 24510240.
Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, et al. (March 2010). "The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate". Cancer Cell. 17 (3): 225–234. doi:10.1016/j.ccr.2010.01.020. PMC 2849316. PMID 20171147.
Wang Y, Xiao M, Chen X, Chen L, Xu Y, Lv L, et al. (February 2015). "WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation". Molecular Cell. 57 (4): 662–673. doi:10.1016/j.molcel.2014.12.023. PMC 4336627. PMID 25601757.
Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, et al. (June 2010). "Cancer-associated IDH1 mutations produce 2-hydroxyglutarate". Nature. 465 (7300): 966. Bibcode:2010Natur.465..966D. doi:10.1038/nature09132. PMC 3766976. PMID 20559394.
Chowdhury R, Yeoh KK, Tian YM, Hillringhaus L, Bagg EA, Rose NR, et al. (May 2011). "The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases". EMBO Reports. 12 (5): 463–469. doi:10.1038/embor.2011.43. PMC 3090014. PMID 21460794.
Tarhonskaya H, Rydzik AM, Leung IK, Loik ND, Chan MC, Kawamura A, et al. (March 2014). "Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases". Nature Communications. 5: 3423. Bibcode:2014NatCo...5.3423T. doi:10.1038/ncomms4423. PMC 3959194. PMID 24594748.
Koivunen P, Lee S, Duncan CG, Lopez G, Lu G, Ramkissoon S, et al. (February 2012). "Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation". Nature. 483 (7390): 484–488. Bibcode:2012Natur.483..484K. doi:10.1038/nature10898. PMC 3656605. PMID 22343896.
Notarangelo G, Spinelli JB, Perez EM, Baker GJ, Kurmi K, Elia I, et al. (September 2022). "Oncometabolite d-2HG alters T cell metabolism to impair CD8⁺ T cell function". Science. 377 (6614): 1519–1529. Bibcode:2022Sci...377.1519N. doi:10.1126/science.abj5104. PMC 9629749. PMID 36173860. S2CID 252623286.

rcsb.org

PDB: 1CW7; Cherbavaz DB, Lee ME, Stroud RM, Koshland DE (January 2000). "Active site water molecules revealed in the 2.1 A resolution structure of a site-directed mutant of isocitrate dehydrogenase". Journal of Molecular Biology. 295 (3): 377–385. doi:10.1006/jmbi.1999.3195. PMID 10623532.
PDB: 1LWD; Ceccarelli C, Grodsky NB, Ariyaratne N, Colman RF, Bahnson BJ (November 2002). "Crystal structure of porcine mitochondrial NADP+-dependent isocitrate dehydrogenase complexed with Mn2+ and isocitrate. Insights into the enzyme mechanism". The Journal of Biological Chemistry. 277 (45): 43454–43462. doi:10.1074/jbc.M207306200. PMID 12207025.

semanticscholar.org

api.semanticscholar.org

Brewer KI, Greenlee EB, Higgs G, Yu D, Mirihana Arachchilage G, Chen X, et al. (December 2021). "Comprehensive discovery of novel structured noncoding RNAs in 26 bacterial genomes". RNA Biology. 18 (12): 2417–2432. doi:10.1080/15476286.2021.1917891. PMC 8632094. PMID 33970790. S2CID 234361097.
Capper D, Zentgraf H, Balss J, Hartmann C, von Deimling A (November 2009). "Monoclonal antibody specific for IDH1 R132H mutation". Acta Neuropathologica. 118 (5): 599–601. doi:10.1007/s00401-009-0595-z. PMID 19798509. S2CID 36093146.
Zarei M, Hue JJ, Hajihassani O, Graor HJ, Katayama ES, Loftus AW, et al. (February 2022). "Clinical development of IDH1 inhibitors for cancer therapy". Cancer Treatment Reviews. 103: 102334. doi:10.1016/j.ctrv.2021.102334. PMID 34974243. S2CID 245547597.
Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, et al. (December 2010). "Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas" (PDF). Acta Neuropathologica. 120 (6): 707–718. doi:10.1007/s00401-010-0781-z. PMID 21088844. S2CID 7323032.
Amary MF, Damato S, Halai D, Eskandarpour M, Berisha F, Bonar F, et al. (November 2011). "Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2". Nature Genetics. 43 (12): 1262–1265. doi:10.1038/ng.994. PMID 22057236. S2CID 5592593.
Notarangelo G, Spinelli JB, Perez EM, Baker GJ, Kurmi K, Elia I, et al. (September 2022). "Oncometabolite d-2HG alters T cell metabolism to impair CD8⁺ T cell function". Science. 377 (6614): 1519–1529. Bibcode:2022Sci...377.1519N. doi:10.1126/science.abj5104. PMC 9629749. PMID 36173860. S2CID 252623286.

uzh.ch

zora.uzh.ch

Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, et al. (December 2010). "Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas" (PDF). Acta Neuropathologica. 120 (6): 707–718. doi:10.1007/s00401-010-0781-z. PMID 21088844. S2CID 7323032.